SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : wla(warner lambert)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: trevor john wilkinson who wrote ()3/5/1999 5:42:00 PM
From: vulture  Read Replies (2) of 942
 
So how come the following news doesn't trigger a price jump on WLA stock?

Biotech company Agouron Pharmaceuticals Inc. (Nasdaq:AGPH -
news) said its researchers have cracked the design of an enzyme that facilitates a process by which
cancerous tumors are able to grow and spread.

By cracking the three-dimensional atomic crystal structure of the VEGFR2 kinase, scientists can develop
drugs that block angiogenesis, the process by which new blood vessels are formed and can contribute to the spread of cancer.

''By blocking the process of angiogenesis, we aim to starve a tumor of its essential blood supply,'' Dr. Patrick O'Connor, chief of oncology research.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext